This webinar is the first in a two-part CAR T webinar series and will highlight two talks from the 2025 Tandem Meetings.
by ASTCT Talks
In this episode of ASTCT Talks, Dr. Corey Cutler sits down with Dr. Ana Barata to discuss the critical role of physician-patient communication in GVHD and stem cell transplantation.
by Science
Researchers present evidence, collected from several tumor models in mice, demonstrating the benefits of inhibition of interferon γ (IFN-γ) signaling in the setting of both hematologic and solid...
by Science
Chimeric antigen receptor (CAR) T-cell efficacy against solid tumors has room for improvement, and researchers are exploring low-dose radiation as one possible pathway to better outcomes.
by The New England Journal of Medicine
Researchers believe an "armored" chimeric antigen receptor (CAR) T-cell product could achieve durable remission in lymphoma patients whose previous anti-CD19 CAR T therapy failed. In...
by Blood Advances
A retrospective analysis shows brexucabtagene autoleucel (brexu-cel), a chimeric antigen receptor (CAR) T-cell therapy, is safe and effective for people with relapsed/refractory B-cell acute...